Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 194, January 1, 2007. doi: 10.1158/0008-5472.CAN-06-3396
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Zinn Supplementary Data
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zinn, R. L.
Right arrow Articles by Herman, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zinn, R. L.
Right arrow Articles by Herman, J. G.

Cell, Tumor, and Stem Cell Biology

hTERT Is Expressed in Cancer Cell Lines Despite Promoter DNA Methylation by Preservation of Unmethylated DNA and Active Chromatin around the Transcription Start Site

Rebekah L. Zinn1,2, Kevin Pruitt1, Sayaka Eguchi1, Stephen B. Baylin1,2 and James G. Herman1,2

1 Sidney Kimmel Comprehensive Cancer Center and 2 Graduate Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

Requests for reprints: James G. Herman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Suite 541, 1650 Orleans Street, Baltimore, MD 21231. Phone: 410-955-8506; Fax: 410-614-9884; E-mail: hermanji{at}jhmi.edu.

hTERT, which encodes the catalytic subunit of telomerase and is expressed in most immortalized and cancer cells, has been reported to have increased DNA methylation in its promoter region in many cancers. This pattern is inconsistent with observations that DNA methylation of promoter CpG islands is typically associated with gene silencing. Here, we provide a comprehensive analysis of promoter DNA methylation, chromatin patterns, and expression of hTERT in cancer and immortalized cells. Methylation-specific PCR and bisulfite sequencing of the hTERT promoter in breast, lung, and colon cancer cells show that all cancer cell lines retain alleles with little or no methylation around the transcription start site despite being densely methylated in a region 600 bp upstream of the transcription start site. By real-time reverse transcription-PCR, all cancer cell lines express hTERT. Chromatin immunoprecipitation (ChIP) analysis reveals that both active (acetyl-H3K9 and dimethyl-H3K4) and inactive (trimethyl-H3K9 and trimethyl-H3K27) chromatin marks are present across the hTERT promoter. However, using a novel approach combining methylation analysis of ChIP DNA, we show that active chromatin marks are associated with unmethylated DNA, whereas inactive marks of chromatin are associated with methylated DNA in the region around the transcription start site. These results show that DNA methylation patterns of the hTERT promoter (–150 to +150 around the transcription start) are consistent with the usual dynamics of gene expression in that the absence of methylation in this region and the association with active chromatin marks allow for the continued expression of hTERT. [Cancer Res 2007;67(1):194–201]




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. Novak, T. J. Jensen, J. C. Garbe, M. R. Stampfer, and B. W. Futscher
Stepwise DNA Methylation Changes Are Linked to Escape from Defined Proliferation Barriers and Mammary Epithelial Cell Immortalization
Cancer Res., June 15, 2009; 69(12): 5251 - 5258.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Chatagnon, S. Bougel, L. Perriaud, J. Lachuer, J. Benhattar, and R. Dante
Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells
Carcinogenesis, January 1, 2009; 30(1): 28 - 34.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
G. P. Srivastava, J. Guo, H. Shi, and D. Xu
PRIMEGENS-v2: genome-wide primer design for analyzing DNA methylation patterns of CpG islands
Bioinformatics, September 1, 2008; 24(17): 1837 - 1842.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Xu, J. Dwyer, H. Li, W. Duan, and J.-P. Liu
Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc
J. Biol. Chem., August 29, 2008; 283(35): 23567 - 23580.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. D.F. Licchesi, W. H. Westra, C. M. Hooker, and J. G. Herman
Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the Lung
Clin. Cancer Res., May 1, 2008; 14(9): 2570 - 2578.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.